<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: liver cancer</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>First live targeting of tumors with RNA-based technology</title>
   	 <description>(PhysOrg.com) -- Finding and treating a tumor without disturbing normal tissue presents challenges - sometimes the most effective therapies can be invasive and harsh.</description>
     <link>http://www.physorg.com/news178804691.html</link>
	 <category>Chemistry</category>
	 <pubDate>Mon, 30 Nov 2009 11:58:49 EST</pubDate>
	 <guid isPermaLink="false">news178804691</guid>
</item>
<item>
     <title>Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US</title>
   	 <description>Researchers from the University of Michigan determined that only 663,000 of the approximately 3.9 million Americans with hepatitis C virus (HCV) infection received antiviral therapy between 2002 and 2007.  Treatment rates appear to be declining, in part because only half of the patients know they are infected.  If this disturbing trend continues, by 2030 less than 15% of liver-related deaths from HCV will be prevented by antiviral therapy.  This study, the first to analyze nationwide practice patterns for HCV treatment, is published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.</description>
     <link>http://www.physorg.com/news178264993.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 24 Nov 2009 06:50:01 EST</pubDate>
	 <guid isPermaLink="false">news178264993</guid>
</item>
<item>
     <title>Radiology procedure may help increase long-term survival in patients with severe liver cancer</title>
   	 <description>In patients with unresectable (unable to be removed by surgery) liver cancer, an interventional radiology procedure called triple-drug transcatheter arterial chemoemobolization (TACE) followed by a liver transplant may significantly increase a patient's chance of long-term survival, according to a study published in the December issue of the American Journal of Roentgenology.</description>
     <link>http://www.physorg.com/news177945840.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 20 Nov 2009 13:24:39 EST</pubDate>
	 <guid isPermaLink="false">news177945840</guid>
</item>
<item>
     <title>Trigger of deadly food toxin discovered</title>
   	 <description>(PhysOrg.com) -- A toxin produced by mold on nuts and grains can cause liver cancer if consumed in large quantities. UC Irvine researchers for the first time have discovered what triggers the toxin to form, which could lead to methods of limiting its production.</description>
     <link>http://www.physorg.com/news175352760.html</link>
	 <category>Chemistry</category>
	 <pubDate>Wed, 21 Oct 2009 14:06:47 EST</pubDate>
	 <guid isPermaLink="false">news175352760</guid>
</item>
<item>
     <title>Elevated lymphotoxin expression in liver leads to chronic hepatitis and causes HCC</title>
   	 <description>A recent study maps the pathway that leads from infection with Hepatitis B and C virus (HBV and HCV) to chronic hepatitis and liver cancer and proposes a new therapeutic strategy for treating liver diseases with chronic inflammation. The research, published by Cell Press in the October issue of the journal Cancer Cell, describes a signaling pathway that can be beneficial during liver regeneration, but can lead to chronic hepatitis and severe liver damage when chronically activated. The research was performed in the Department of Pathology, Institutes of Clinical Pathology and Neuropathology at the University Hospital in Zurich.</description>
     <link>http://www.physorg.com/news173968463.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 05 Oct 2009 14:10:08 EST</pubDate>
	 <guid isPermaLink="false">news173968463</guid>
</item>
<item>
     <title>A Twist in the Genome Thwarts Hepatitis C</title>
   	 <description>(PhysOrg.com) -- Viruses like Hepatitis C proliferate by tricking cellular machinery into manufacturing the parts for duplicate viral particles. </description>
     <link>http://www.physorg.com/news173549327.html</link>
	 <category>Chemistry</category>
	 <pubDate>Wed, 30 Sep 2009 17:09:14 EST</pubDate>
	 <guid isPermaLink="false">news173549327</guid>
</item>
<item>
     <title>Research isolates liver cancer stem cells prior to tumor formation</title>
   	 <description>Penn State College of Medicine researchers, in collaboration with colleagues at the University of Southern California, have taken an important step in understanding the role of stem cells in development of liver cancer. Using a unique approach that involves study of individual cells, the team, led by C. Bart Rountree, M.D., has demonstrated for the first time a population of cancer stem cells in the liver prior to tumor formation. The research, published in the journal Stem Cells, shows a potential link between liver stem cells and liver cancer.</description>
     <link>http://www.physorg.com/news172424170.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 17 Sep 2009 16:50:02 EST</pubDate>
	 <guid isPermaLink="false">news172424170</guid>
</item>
<item>
     <title>Cases of liver cancer reduced in a younger population vaccinated for HBV</title>
   	 <description>A 20-year follow-up study revealed a dramatic drop in liver cancer cases among 6- to 19-year-olds who were vaccinated for the hepatitis B virus at birth, according to a study published online September 16 in the Journal of the National Cancer Institute.</description>
     <link>http://www.physorg.com/news172337405.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 16 Sep 2009 16:35:12 EST</pubDate>
	 <guid isPermaLink="false">news172337405</guid>
</item>
<item>
     <title>Current hepatitis C treatments work equally well, researchers report</title>
   	 <description>The three treatment combinations for clearing the most common form of the hepatitis C virus work equally well with similar side effects, UT Southwestern Medical Center researchers and their colleagues in 13 other institutions have found. Hepatitis C affects nearly 4 million Americans and leads to cirrhosis and liver cancer but can be arrested permanently in many patients.</description>
     <link>http://www.physorg.com/news168857842.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 07 Aug 2009 09:57:45 EST</pubDate>
	 <guid isPermaLink="false">news168857842</guid>
</item>
<item>
     <title>SAMe is effective in preventing formation of primary liver cancer in rats</title>
   	 <description>A new study investigated the effectiveness of S-adenosylmethionine (SAMe) in the prevention and treatment of hepatocellular carcinoma (HCC) or primary liver cancer.  SAMe, a widely available nutritional supplement, with little known side effects, was found to be effective in preventing the formation of HCC in rats.  However, high enough levels of SAMe were not attainable to successfully treat established HCC.  The findings are available in the August issue of Hepatology, a journal published by John Wiley &amp; Sons on behalf of the American Association for the Study of Liver Diseases.</description>
     <link>http://www.physorg.com/news168181552.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 30 Jul 2009 14:21:07 EST</pubDate>
	 <guid isPermaLink="false">news168181552</guid>
</item>
<item>
     <title>Researchers identify genes linked to chemoresistance</title>
   	 <description>Two genes may contribute to chemotherapy resistance in drugs like 5-fluorouracil, which is used in liver cancer treatment, according to Virginia Commonwealth University Massey Cancer Center researchers.</description>
     <link>http://www.physorg.com/news167325348.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Jul 2009 16:16:45 EST</pubDate>
	 <guid isPermaLink="false">news167325348</guid>
</item>
<item>
     <title>NY hospital warns of possible hepatitis exposures</title>
   	 <description>(AP) --  A hospital in New York state is notifying about 2,800 patients of possible exposure to hepatitis C after learning that a former employee is suspected of exposing nearly 6,000 patients in Colorado to the disease.</description>
     <link>http://www.physorg.com/news166941080.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 16 Jul 2009 05:31:58 EST</pubDate>
	 <guid isPermaLink="false">news166941080</guid>
</item>
<item>
     <title>Gene's novel role may provide key to treating liver and neurodegenerative diseases</title>
   	 <description>Scientists at Singapore's Bioprocessing Technology Institute (BTI) have made a novel discovery about how the gene, "Fas-apoptosis inhibitory molecule" (FAIM), protects both immune and liver cells from apoptosis, or programmed cell death.</description>
     <link>http://www.physorg.com/news165825938.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 03 Jul 2009 07:46:05 EST</pubDate>
	 <guid isPermaLink="false">news165825938</guid>
</item>
<item>
     <title>Study examines dietary influences of liver disease</title>
   	 <description>Diets high in protein and cholesterol are associated with a higher risk of hospitalization or death due to cirrhosis or liver cancer, while diets high in carbohydrates are associated with a lower risk. These findings are in the July issue of Hepatology, a journal published by John Wiley &amp; Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://www.physorg.com/news165671019.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Jul 2009 12:44:01 EST</pubDate>
	 <guid isPermaLink="false">news165671019</guid>
</item>
<item>
     <title>Targeting tumor behavior may lead to new liver cancer drugs</title>
   	 <description>Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior. The agents target multiple genes associated with that behavior at one time.</description>
     <link>http://www.physorg.com/news164547226.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 18 Jun 2009 12:50:02 EST</pubDate>
	 <guid isPermaLink="false">news164547226</guid>
</item>
<item>
     <title>Good news for some hard-to-treat hepatitis C patients</title>
   	 <description>In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to previous treatment. The findings, published in the June issue of Hepatology, offer a new option for hepatitis C patients, and may be effective even for those patients with factors that make their condition difficult to treat.</description>
     <link>http://www.physorg.com/news164360551.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 16 Jun 2009 09:10:01 EST</pubDate>
	 <guid isPermaLink="false">news164360551</guid>
</item>
<item>
     <title>DKK-3 and WIF-1: Proteins related to liver cancer development?</title>
   	 <description>Liver cancer is one of the most fatal human malignancies and the third most frequent cause of tumor-related death, about half a million people globally each year. The current methods used to monitor such high-risk groups include ultrasound scans and a test for the presence of a single protein in the blood called alpha-fetoprotein. It is a good indicator of advanced liver cancer, but less able to detect early disease. So it is the most impotent thing is find the changes of biomarker combinations in the early period of diseases, control the key gene in the initial stage of disease and reverse the development of disease.</description>
     <link>http://www.physorg.com/news164278973.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 15 Jun 2009 10:03:12 EST</pubDate>
	 <guid isPermaLink="false">news164278973</guid>
</item>
<item>
     <title>Low-fat diet helps genetically predisposed animals avoid liver cancer</title>
   	 <description>In a study comparing two strains of mice, one susceptible to developing cancer and the other not, researchers found that a high-fat diet predisposed the cancer-susceptible strain to liver cancer, and that by switching to a low-fat diet early in the experiment, the same high-risk mice avoided the malignancy. The switched mice were lean rather than obese and had healthy livers at the end of the study.</description>
     <link>http://www.physorg.com/news163989266.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 12 Jun 2009 06:50:02 EST</pubDate>
	 <guid isPermaLink="false">news163989266</guid>
</item>
<item>
     <title>Study shows promise for new cancer-stopping therapy</title>
   	 <description>Researchers at Nationwide Children's Hospital and Johns Hopkins University have discovered that delivering a small molecule that is highly expressed in normal tissues but lost in diseased cells can result in tumor suppression.</description>
     <link>http://www.physorg.com/news163942021.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 11 Jun 2009 12:28:26 EST</pubDate>
	 <guid isPermaLink="false">news163942021</guid>
</item>
<item>
     <title>Stem cell protein offers a new cancer target</title>
   	 <description>A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston.</description>
     <link>http://www.physorg.com/news163081825.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Jun 2009 13:33:06 EST</pubDate>
	 <guid isPermaLink="false">news163081825</guid>
</item>
<item>
     <title>Worldwide success in treatment of liver tumors</title>
   	 <description>Leicester consultant surgeon who has developed a pioneering technique using microwaves to destroy liver tumours has treated more than 100 patients in the UK and other patients are now being treated internationally.</description>
     <link>http://www.physorg.com/news161347636.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 12 May 2009 11:47:49 EST</pubDate>
	 <guid isPermaLink="false">news161347636</guid>
</item>
<item>
     <title>Study indicates cancer preventive effect for statins</title>
   	 <description>The commonly used prescription statin drugs may have a protective effect in the prevention of liver cancer and lead to a reduction in the need for gallbladder removals, according to two studies published in Gastroenterology. As millions of Americans use statins each day to help lower their cholesterol and risk of heart disease, researchers are learning of the beneficial effects these drugs may have on gastrointestinal disorders. Gastroenterology is the official journal of the American Gastroenterological Association (AGA) Institute.</description>
     <link>http://www.physorg.com/news160756410.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 05 May 2009 15:33:58 EST</pubDate>
	 <guid isPermaLink="false">news160756410</guid>
</item>
<item>
     <title>Hypothyroidism in women associated with liver cancer</title>
   	 <description>Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer, according to a new study in the May issue of Hepatology, a journal published by John Wiley &amp; Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). </description>
     <link>http://www.physorg.com/news160656514.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 04 May 2009 11:48:48 EST</pubDate>
	 <guid isPermaLink="false">news160656514</guid>
</item>
<item>
     <title>Medication may improve portal hypertension</title>
   	 <description>In a new study, a therapeutic agent called sorafenib dramatically improved the condition of rats with portal hypertension. The drug is already approved in several countries for treatment of kidney and liver cancer, and it may be time to consider it for patients suffering from advanced portal hypertension, the authors suggest. Their findings are in the April issue of Hepatology, a journal published by John Wiley &amp; Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://www.physorg.com/news157810010.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Apr 2009 13:07:50 EST</pubDate>
	 <guid isPermaLink="false">news157810010</guid>
</item>
<item>
     <title>Scots and Irish at greater risk of drink-related death, study shows</title>
   	 <description>Alcohol-related deaths in England and Wales are twice as high among people born in Scotland or Ireland compared with the rest of the population, a study has shown.</description>
     <link>http://www.physorg.com/news156713753.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 19 Mar 2009 20:36:39 EST</pubDate>
	 <guid isPermaLink="false">news156713753</guid>
</item>
<item>
     <title>Liver tumors associated with metabolic syndrome differ from other tumors</title>
   	 <description>Liver cancer in patients whose only risk factor is metabolic syndrome has distinct forms and structures compared to other liver tumors. These findings are in the March issue of Hepatology, a journal published by John Wiley &amp; Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). </description>
     <link>http://www.physorg.com/news154789424.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 25 Feb 2009 13:04:46 EST</pubDate>
	 <guid isPermaLink="false">news154789424</guid>
</item>
<item>
     <title>New analysis shows liver cancer incidence has tripled since 1970s, but survival rates improving</title>
   	 <description>A new study examining data on incidence trends, mortality rates and survival rates from the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) cancer registries indicates that the incidence of liver cancer in the United States tripled between 1975 and 2005.</description>
     <link>http://www.physorg.com/news154191005.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 18 Feb 2009 14:50:45 EST</pubDate>
	 <guid isPermaLink="false">news154191005</guid>
</item>
<item>
     <title>Researchers Identify Gene Linked to Aggressive Progression of Liver Cancer</title>
   	 <description>(PhysOrg.com) -- Virginia Commonwealth University researchers have identified a gene that plays a key role in regulating liver cancer progression, a discovery that could one day lead to new targeted therapeutic strategies to fight the highly aggressive disease.</description>
     <link>http://www.physorg.com/news154109542.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 17 Feb 2009 16:12:55 EST</pubDate>
	 <guid isPermaLink="false">news154109542</guid>
</item>
<item>
     <title>Genetic signature predicts outcome of pediatric liver cancer</title>
   	 <description>Scientists have identified a genetic signature that is remarkably effective at predicting the prognosis of an aggressive liver cancer in children. The research, published by Cell Press in the December issue of the journal Cancer Cell, may lead to better treatments for pediatric liver cancers.</description>
     <link>http://www.physorg.com/news147965816.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 08 Dec 2008 13:36:56 EST</pubDate>
	 <guid isPermaLink="false">news147965816</guid>
</item>
<item>
     <title>Liver transplant recipients have higher cancer risk</title>
   	 <description>A new Canadian study comparing cancer rates of liver transplant patients to those of the general population has found that transplant recipients face increased risks of developing cancer, especially non-Hodgkin's lymphoma and colorectal cancer. Risks were more pronounced during the first year of follow-up and among younger transplant recipients. These findings are published in the November issue of Liver Transplantation, a journal by John Wiley &amp; Sons.</description>
     <link>http://www.physorg.com/news144946240.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 03 Nov 2008 14:50:40 EST</pubDate>
	 <guid isPermaLink="false">news144946240</guid>
</item>


</channel>
</rss>

